HEMATOXYLIN
HEMATOXYLIN is a lipid of Polyketides (PK) class. Hematoxylin is associated with abnormalities such as Eosinophilia, Duodenal Adenoma, Senile Plaques, Morphologically altered structure and Cervical abscess. The involved functions are known as Uptake, Apoptosis, Amplification, Necrosis and Karyopyknosis. Hematoxylin often locates in Body tissue, Extracellular, Compact bone, Skin and Basement membrane. The associated genes with HEMATOXYLIN are GAPDH gene, Genome, Elastin, MERTK wt Allele and P4HTM gene.
Cross Reference
Introduction
To understand associated biological information of HEMATOXYLIN, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with HEMATOXYLIN?
HEMATOXYLIN is suspected in Senile Plaques, Eosinophilia, Duodenal Adenoma, Morphologically altered structure, Cervical abscess and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with HEMATOXYLIN
PubChem Associated disorders and diseases
What pathways are associated with HEMATOXYLIN
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with HEMATOXYLIN?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
- Am. J. Physiol. Heart Circ. Physiol. (3)
- Proc. Natl. Acad. Sci. U.S.A. (1)
- Stem Cells Transl Med (1)
- Others (13)
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with HEMATOXYLIN?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with HEMATOXYLIN?
There are no associated biomedical information in the current reference collection.
What genes are associated with HEMATOXYLIN?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with HEMATOXYLIN?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with HEMATOXYLIN
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Aoki M et al. | Expression of BMP-7 in human gastric cancer and its clinical significance. | 2011 | Br. J. Cancer | pmid:21224856 |
| Maeda S et al. | Clinical significance of midkine expression in pancreatic head carcinoma. | 2007 | Br. J. Cancer | pmid:17622248 |
| Kawaguchi Y et al. | Targeting EGFR and HER-2 with cetuximab- and trastuzumab-mediated immunotherapy in oesophageal squamous cell carcinoma. | 2007 | Br. J. Cancer | pmid:17622245 |
| Liu WM et al. | Inhibition of metastatic potential in colorectal carcinoma in vivo and in vitro using immunomodulatory drugs (IMiDs). | 2009 | Br. J. Cancer | pmid:19638977 |
| Konishi N et al. | Overexpression of leucocyte common antigen (LAR) P-subunit in thyroid carcinomas. | 2003 | Br. J. Cancer | pmid:12698188 |
| Takizawa S et al. | Abnormal Fhit expression is an independent poor prognostic factor for cervical cancer. | 2003 | Br. J. Cancer | pmid:12698186 |
| Eichenmüller M et al. | Betulinic acid induces apoptosis and inhibits hedgehog signalling in rhabdomyosarcoma. | 2010 | Br. J. Cancer | pmid:20517313 |
| Nakagawa S et al. | Analysis of the expression and localisation of a LAP protein, human scribble, in the normal and neoplastic epithelium of uterine cervix. | 2004 | Br. J. Cancer | pmid:14710229 |
| Brownhill SC et al. | Chromosome 9p21 gene copy number and prognostic significance of p16 in ESFT. | 2007 | Br. J. Cancer | pmid:17533400 |
| Lorch G et al. | Inhibition of epidermal growth factor receptor signalling reduces hypercalcaemia induced by human lung squamous-cell carcinoma in athymic mice. | 2007 | Br. J. Cancer | pmid:17533397 |
| Pardo FS et al. | Mutant, wild type, or overall p53 expression: freedom from clinical progression in tumours of astrocytic lineage. | 2004 | Br. J. Cancer | pmid:15494720 |
| Abd El-Rehim DM et al. | Expression and co-expression of the members of the epidermal growth factor receptor (EGFR) family in invasive breast carcinoma. | 2004 | Br. J. Cancer | pmid:15480434 |
| Bjørge T et al. | BRCA1 mutations in ovarian cancer and borderline tumours in Norway: a nested case-control study. | 2004 | Br. J. Cancer | pmid:15477862 |
| Spizzo G et al. | Correlation of COX-2 and Ep-CAM overexpression in human invasive breast cancer and its impact on survival. | 2003 | Br. J. Cancer | pmid:12592372 |
| Pelosi G et al. | Independent prognostic value of fascin immunoreactivity in stage I nonsmall cell lung cancer. | 2003 | Br. J. Cancer | pmid:12592367 |
| Unoki M et al. | UHRF1 is a novel diagnostic marker of lung cancer. | 2010 | Br. J. Cancer | pmid:20517312 |
| Millar EK et al. | BAG-1 predicts patient outcome and tamoxifen responsiveness in ER-positive invasive ductal carcinoma of the breast. | 2009 | Br. J. Cancer | pmid:19066611 |
| Li Q et al. | Expression of interferon-gamma in human adrenal gland and kidney tumours. | 2007 | Br. J. Cancer | pmid:17622250 |
| Nishikawa M et al. | Accumulation of mitochondrial DNA mutation with colorectal carcinogenesis in ulcerative colitis. | 2005 | Br. J. Cancer | pmid:15956973 |
| Onda M et al. | Decreased expression of haemoglobin beta (HBB) gene in anaplastic thyroid cancer and recovery of its expression inhibits cell growth. | 2005 | Br. J. Cancer | pmid:15956966 |
| Ni X et al. | Characterisation of human kallikrein 6/protease M expression in ovarian cancer. | 2004 | Br. J. Cancer | pmid:15305183 |
| Takano T et al. | BRAF V600E mutation in anaplastic thyroid carcinomas and their accompanying differentiated carcinomas. | 2007 | Br. J. Cancer | pmid:17453004 |
| Koukourakis MI et al. | Lactate dehydrogenase-5 (LDH-5) overexpression in non-small-cell lung cancer tissues is linked to tumour hypoxia, angiogenic factor production and poor prognosis. | 2003 | Br. J. Cancer | pmid:12942121 |
| Grunewald TG et al. | Overexpression of LASP-1 mediates migration and proliferation of human ovarian cancer cells and influences zyxin localisation. | 2007 | Br. J. Cancer | pmid:17211471 |
| Fareed KR et al. | Tumour regression and ERCC1 nuclear protein expression predict clinical outcome in patients with gastro-oesophageal cancer treated with neoadjuvant chemotherapy. | 2010 | Br. J. Cancer | pmid:20461087 |
| Frietsch JJ et al. | Nuclear localisation of LASP-1 correlates with poor long-term survival in female breast cancer. | 2010 | Br. J. Cancer | pmid:20461080 |
| Bibi R et al. | A specific cadherin phenotype may characterise the disseminating yet non-metastatic behaviour of pseudomyxoma peritonei. | 2006 | Br. J. Cancer | pmid:17031402 |
| Bruland O et al. | Gene expression reveals two distinct groups of anal carcinomas with clinical implications. | 2008 | Br. J. Cancer | pmid:18349847 |
| Yoshioka T et al. | Infiltrating regulatory T cell numbers is not a factor to predict patient's survival in oesophageal squamous cell carcinoma. | 2008 | Br. J. Cancer | pmid:18349839 |
| Maeda S et al. | CD133 expression is correlated with lymph node metastasis and vascular endothelial growth factor-C expression in pancreatic cancer. | 2008 | Br. J. Cancer | pmid:18349830 |
| Puppa G et al. | Independent prognostic value of fascin immunoreactivity in stage III-IV colonic adenocarcinoma. | 2007 | Br. J. Cancer | pmid:17375048 |
| Mukherjee R et al. | Upregulation of MAPK pathway is associated with survival in castrate-resistant prostate cancer. | 2011 | Br. J. Cancer | pmid:21559022 |
| Schmitz M et al. | Identification of SOX2 as a novel glioma-associated antigen and potential target for T cell-based immunotherapy. | 2007 | Br. J. Cancer | pmid:17375044 |
| Elsir T et al. | PROX1 is a predictor of survival for gliomas WHO grade II. | 2011 | Br. J. Cancer | pmid:21559010 |
| Comstock CE et al. | Impact of differential cyclin D1 expression and localisation in prostate cancer. | 2007 | Br. J. Cancer | pmid:17375037 |
| Ogawa E et al. | Clinical significance of VEGF-C status in tumour cells and stromal macrophages in non-small cell lung cancer patients. | 2004 | Br. J. Cancer | pmid:15226767 |
| Shehata M et al. | Human leukocyte antigen class I expression is an independent prognostic factor in advanced ovarian cancer resistant to first-line platinum chemotherapy. | 2009 | Br. J. Cancer | pmid:19755991 |
| Lugli A et al. | CD8+ lymphocytes/ tumour-budding index: an independent prognostic factor representing a 'pro-/anti-tumour' approach to tumour host interaction in colorectal cancer. | 2009 | Br. J. Cancer | pmid:19755986 |
| Angst E et al. | Cellular differentiation determines the expression of the hypoxia-inducible protein NDRG1 in pancreatic cancer. | 2006 | Br. J. Cancer | pmid:16832411 |
| Chen YL et al. | Granulocytes mediates the Fas-L-associated apoptosis during lung metastasis of melanoma that determines the metastatic behaviour. | 2002 | Br. J. Cancer | pmid:12177809 |
| Baeten CI et al. | Flow cytometric quantification of tumour endothelial cells; an objective alternative for microvessel density assessment. | 2002 | Br. J. Cancer | pmid:12177806 |
| Somlo G et al. | Predictors of long-term outcome following high-dose chemotherapy in high-risk primary breast cancer. | 2002 | Br. J. Cancer | pmid:12177795 |
| Volm M et al. | Protein expression profiles indicative for drug resistance of non-small cell lung cancer. | 2002 | Br. J. Cancer | pmid:12177790 |
| Sheridan J et al. | Nuclear oxidative damage correlates with poor survival in colorectal cancer. | 2009 | Br. J. Cancer | pmid:19066606 |
| Ameri K et al. | Circulating tumour cells demonstrate an altered response to hypoxia and an aggressive phenotype. | 2010 | Br. J. Cancer | pmid:20051957 |
| van Beers EH et al. | A multiplex PCR predictor for aCGH success of FFPE samples. | 2006 | Br. J. Cancer | pmid:16333309 |
| Batistatou A et al. | Involvement of dysadherin and E-cadherin in the development of testicular tumours. | 2005 | Br. J. Cancer | pmid:16333245 |
| McCallum M et al. | A prognostic index for operable, node-negative breast cancer. | 2004 | Br. J. Cancer | pmid:15138474 |
| Chakraborty S et al. | Constitutive androstane receptor agonist CITCO inhibits growth and expansion of brain tumour stem cells. | 2011 | Br. J. Cancer | pmid:21224854 |
| Matsuyoshi S et al. | FADD phosphorylation is critical for cell cycle regulation in breast cancer cells. | 2006 | Br. J. Cancer | pmid:16450001 |
| Hart CA et al. | Role of proteolytic enzymes in human prostate bone metastasis formation: in vivo and in vitro studies. | 2002 | Br. J. Cancer | pmid:11953862 |
| Shinto O et al. | Inhibitory effect of a TGFbeta receptor type-I inhibitor, Ki26894, on invasiveness of scirrhous gastric cancer cells. | 2010 | Br. J. Cancer | pmid:20145621 |
| Ueno Y et al. | Selective inhibition of TNF-alpha-induced activation of mitogen-activated protein kinases and metastatic activities by gefitinib. | 2005 | Br. J. Cancer | pmid:15841081 |
| Kölby L et al. | Successful receptor-mediated radiation therapy of xenografted human midgut carcinoid tumour. | 2005 | Br. J. Cancer | pmid:16251870 |
| Hosono S et al. | Expression of Twist increases the risk for recurrence and for poor survival in epithelial ovarian carcinoma patients. | 2007 | Br. J. Cancer | pmid:17211477 |
| Kamoshida S et al. | Immunostaining of thymidylate synthase and p53 for predicting chemoresistance to S-1/cisplatin in gastric cancer. | 2007 | Br. J. Cancer | pmid:17211470 |
| Grützmann R et al. | ADAM9 expression in pancreatic cancer is associated with tumour type and is a prognostic factor in ductal adenocarcinoma. | 2004 | Br. J. Cancer | pmid:14997207 |
| Vicent S et al. | ERK1/2 is activated in non-small-cell lung cancer and associated with advanced tumours. | 2004 | Br. J. Cancer | pmid:14997206 |
| Savinainen KJ et al. | Expression and copy number analysis of TRPS1, EIF3S3 and MYC genes in breast and prostate cancer. | 2004 | Br. J. Cancer | pmid:14997205 |
| Takemoto S et al. | Expression of activated signal transducer and activator of transcription-3 predicts poor prognosis in cervical squamous-cell carcinoma. | 2009 | Br. J. Cancer | pmid:19638983 |
| Cheng Q et al. | Identification of molecular markers for the early detection of human squamous cell carcinoma of the uterine cervix. | 2002 | Br. J. Cancer | pmid:11870519 |
| Brooks LA et al. | E7 proteins from oncogenic human papillomavirus types transactivate p73: role in cervical intraepithelial neoplasia. | 2002 | Br. J. Cancer | pmid:11870517 |
| Horiguchi J et al. | Prognostic significance of dihydropyrimidine dehydrogenase expression in breast cancer. | 2002 | Br. J. Cancer | pmid:11870510 |
| Almstrup K et al. | Carcinoma in situ testis displays permissive chromatin modifications similar to immature foetal germ cells. | 2010 | Br. J. Cancer | pmid:20823885 |
| Ivarsson K et al. | Resistance to tumour challenge after tumour laser thermotherapy is associated with a cellular immune response. | 2005 | Br. J. Cancer | pmid:16091763 |
| Prowatke I et al. | Expression analysis of imbalanced genes in prostate carcinoma using tissue microarrays. | 2007 | Br. J. Cancer | pmid:17146477 |
| Jhavar S et al. | Construction of tissue microarrays from prostate needle biopsy specimens. | 2005 | Br. J. Cancer | pmid:16091762 |
| Theodore Ch et al. | Bilateral germ-cell tumours: 22-year experience at the Institut Gustave Roussy. | 2004 | Br. J. Cancer | pmid:14710206 |
| Myers E et al. | Inverse relationship between ER-beta and SRC-1 predicts outcome in endocrine-resistant breast cancer. | 2004 | Br. J. Cancer | pmid:15477868 |
| Kostourou V et al. | The role of tumour-derived iNOS in tumour progression and angiogenesis. | 2011 | Br. J. Cancer | pmid:21139581 |
| Stoeltzing O et al. | Angiopoietin-1 inhibits tumour growth and ascites formation in a murine model of peritoneal carcinomatosis. | 2002 | Br. J. Cancer | pmid:12402160 |
| Verschoyle RD et al. | Evaluation of the cancer chemopreventive efficacy of rice bran in genetic mouse models of breast, prostate and intestinal carcinogenesis. | 2007 | Br. J. Cancer | pmid:17211473 |
| Knijn N et al. | KRAS mutation analysis: a comparison between primary tumours and matched liver metastases in 305 colorectal cancer patients. | 2011 | Br. J. Cancer | pmid:21364579 |
| Lopez-Crapez E et al. | p53 status and response to radiotherapy in rectal cancer: a prospective multilevel analysis. | 2005 | Br. J. Cancer | pmid:15956964 |
| Dangles V et al. | Gene expression profiles of bladder cancers: evidence for a striking effect of in vitro cell models on gene patterns. | 2002 | Br. J. Cancer | pmid:11953886 |
| Farooqui M et al. | COX-2 inhibitor celecoxib prevents chronic morphine-induced promotion of angiogenesis, tumour growth, metastasis and mortality, without compromising analgesia. | 2007 | Br. J. Cancer | pmid:17971769 |
| Nagourney RA et al. | Ex vivo analysis of topotecan: advancing the application of laboratory-based clinical therapeutics. | 2003 | Br. J. Cancer | pmid:14583785 |
| Yamamoto E et al. | Expression of N-acetylglucosaminyltransferase V in endometrial cancer correlates with poor prognosis. | 2007 | Br. J. Cancer | pmid:17971775 |
| Hagiwara S et al. | Combination therapy with PEG-IFN-alpha and 5-FU inhibits HepG2 tumour cell growth in nude mice by apoptosis of p53. | 2007 | Br. J. Cancer | pmid:17971768 |
| Jenkinson SR et al. | S100A4 regulates cell motility and invasion in an in vitro model for breast cancer metastasis. | 2004 | Br. J. Cancer | pmid:14710237 |
| Al-Attar A et al. | Human apurinic/apyrimidinic endonuclease (APE1) is a prognostic factor in ovarian, gastro-oesophageal and pancreatico-biliary cancers. | 2010 | Br. J. Cancer | pmid:20087352 |
| Jeon TY et al. | Overexpression of stathmin1 in the diffuse type of gastric cancer and its roles in proliferation and migration of gastric cancer cells. | 2010 | Br. J. Cancer | pmid:20087351 |
| Ugurel S et al. | Lack of clinical efficacy of imatinib in metastatic melanoma. | 2005 | Br. J. Cancer | pmid:15846297 |
| Brown NS et al. | Cooperative stimulation of vascular endothelial growth factor expression by hypoxia and reactive oxygen species: the effect of targeting vascular endothelial growth factor and oxidative stress in an orthotopic xenograft model of bladder carcinoma. | 2005 | Br. J. Cancer | pmid:15841086 |
| Langbein S et al. | Expression of transketolase TKTL1 predicts colon and urothelial cancer patient survival: Warburg effect reinterpreted. | 2006 | Br. J. Cancer | pmid:16465194 |
| Wülfing P et al. | Expression patterns of angiogenic and lymphangiogenic factors in ductal breast carcinoma in situ. | 2005 | Br. J. Cancer | pmid:15841074 |
| Vernimmen D et al. | Different mechanisms are implicated in ERBB2 gene overexpression in breast and in other cancers. | 2003 | Br. J. Cancer | pmid:12942124 |
| Seynhaeve AL et al. | Isolated limb perfusion with actinomycin D and TNF-alpha results in improved tumour response in soft-tissue sarcoma-bearing rats but is accompanied by severe local toxicity. | 2002 | Br. J. Cancer | pmid:11953868 |
| Dive C et al. | Considerations for the use of plasma cytokeratin 18 as a biomarker in pancreatic cancer. | 2010 | Br. J. Cancer | pmid:20051949 |
| Lawrie LC et al. | Liver fatty acid binding protein expression in colorectal neoplasia. | 2004 | Br. J. Cancer | pmid:15138477 |
| Radke I et al. | Expression and prognostic impact of the protein tyrosine phosphatases PRL-1, PRL-2, and PRL-3 in breast cancer. | 2006 | Br. J. Cancer | pmid:16832410 |
| Chatrath P et al. | Immunohistochemical estimation of cell cycle phase in laryngeal neoplasia. | 2006 | Br. J. Cancer | pmid:16832409 |
| Fondevila C et al. | p53 and VEGF expression are independent predictors of tumour recurrence and survival following curative resection of gastric cancer. | 2004 | Br. J. Cancer | pmid:14710231 |
| Hashida H et al. | Clinical significance of transmembrane 4 superfamily in colon cancer. | 2003 | Br. J. Cancer | pmid:12838318 |
| Nomura H et al. | Network-based analysis of calcium-binding protein genes identifies Grp94 as a target in human oral carcinogenesis. | 2007 | Br. J. Cancer | pmid:17726464 |
| Yamamoto T et al. | No major tumorigenic role for beta-catenin in serrated as opposed to conventional colorectal adenomas. | 2003 | Br. J. Cancer | pmid:12838317 |
| Horii R et al. | Optimal indications of endocrine therapy alone as adjuvant systemic treatment of breast cancer. | 2007 | Br. J. Cancer | pmid:17726451 |
| Shyu RY et al. | RARRES3 expression positively correlated to tumour differentiation in tissues of colorectal adenocarcinoma. | 2003 | Br. J. Cancer | pmid:12838316 |
| Xue SA et al. | Epstein-Barr virus gene expression in human breast cancer: protagonist or passenger? | 2003 | Br. J. Cancer | pmid:12838311 |
| Southern SA et al. | Induction of tetrasomy by human papillomavirus type 16 E7 protein is independent of pRb binding and disruption of differentiation. | 2004 | Br. J. Cancer | pmid:15138476 |